In a 12-month period that has seen drug compounders linked to horse deaths at a training center and integrity issues at the track, the Kentucky Horse Racing Commission is researching ways it could add regulatory oversight.
The U.S. Food and Drug Administration reports the number of Thoroughbreds who died after receiving a compounded drug from Wickliffe Pharmacy in Lexington, Ky. has grown to four, and six others have become ill.
The RMTC will recommend the anabolic steroid stanozolol, currently permitted for therapeutic use up to 30 days prior to racing, be eliminated from the list of substances with a recommended threshold level.
Scientists are warning horse owners and veterinarians to be cautious about using compounded (private pharmacy-mixed) gastric ulcer medications.
Most Popular Stories
- Firing Line to Crestwood
- Arrogate Works Toward Seasonal Bow
- Juveniles Showcased at Gulfstream Saturday
- NY Again Considers Continuing Ed for Trainers
- Dutchess Views Lowers Fee for Big Brown
- Pure Sensation Questionable for HK Sprint
- BC Juvenile Winner Texas Red Retired
- American Gal, Union Strike Meet in Starlet
- New York Calls Off Belmont Development
- Able Friend Out to Regain Hong Kong Glory